le lundi 22 octobre 2018, à 02:34. Posté
par Clinton
Where are you from? https://www.demaster.cz/stmap_c0a40.html?ondansetron.cialis.lansoprazole custom rx 75 Drugmaker Retrophin Inc said it offered to buy therest of Transcept Pharmaceuticals shares it does not already ownfor $4 per share, valuing Transcept at about $75 million.Retrophin's offer represents an 11 percent premium toTranscept's closing share price of $3.59 on the Nasdaq onWednesday.